Nordson raises full-year guidance after third-quarter record results

On Thursday, Nordson (NASDAQ: NDSN ) discussed third-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more.

Access the full call at Summary Nordson Corporation reported a 10% year-over-year increase in sales for the third quarter of fiscal 2026, reaching $818 million, driven by 12% organic growth across all segments. 25, marking a 19% increase from the previous year. 8 and $12, citing strong backlog growth and order momentum, especially in the Advanced Technology and Medical segments. 7 times, supported by strong free cash flow generation of $237 million, allowing for strategic acquisitions and shareholder returns.

Management emphasized ongoing strategic initiatives, including the execution of the ASCEND strategy and the NBS Next Growth Framework, which focus on maximizing growth potential while maintaining high margins. Full Transcript OPERATOR Thank you for joining us and welcome to the Nordson Corporation third quarter fiscal year 2026 conference call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press star 1 to raise your hand.

To withdraw your question, press star 1 again. I will now hand the conference over to Matt Matejka of Nordson. Matt, please go ahead. Matt Matejka, Senior Director, Investor Relations Thank you.

Good morning. This is Matt Matejka, Senior Director of Investor Relations. I'm here with Sundaram Nagarajan, our President and Chief Executive Officer, and Dan Hopgood, Executive Vice President and Chief Financial Officer. We welcome you to our conference call today, Thursday, August 20th, to report Nordson's fiscal 2026 third quarter results.

You can find both our press release as well as our webcast slide presentation that we will refer to during today's call on our website at This conference call is being broadcast live on our investor website and will be available there for 30 days. During this conference call we will make references to non-GAAP financial metrics. We've provided a reconciliation of these metrics to the most comparable GAAP metric in the press release issued yesterday.

Before we begin, please refer to slide two of our presentation where we note that certain statements regarding our future performance that are made during this call may be forward-looking based upon Nordson's current expectations. These statements may involve a number of risks, uncertainties, and other factors as discussed in the company's filings with the Securities and Exchange Commission that could cause actual results to materially differ. Moving to today's agenda on slide three, Naga will discuss third quarter highlights. He will then turn the call over to Dan to review sales and earnings performance for the total company and the three business segments.

Dan will also discuss the balance sheet and cash flow. Naga will then share a high level commentary about our enterprise performance and provide an update on the fiscal 2026 full year guidance. We will then be happy to take your questions. With that, I'll turn to slide four and turn the call over to Naga.

Sundaram Nagarajan, President and Chief Executive Officer Good morning, everyone. Thank you for joining Nordson's fiscal 2026 third quarter conference call. Before we begin, I would like to welcome Matt Matejka to our call in his new role of Senior Director, Investor Relations. As we announced in a previous press release, Matt has assumed investor relations responsibilities from Lara Mahoney, who has taken on a new role within Nordson.

Matt joined Nordson in 2023 and brings over 10 years of experience in financial leadership roles, most recently serving as Finance Director for our Industrial Coating Solutions division. Moving on to the financial results, I am pleased to share that the momentum driving our strong first half continued throughout the third quarter. For the first nine months of fiscal 2026, Nordson has grown revenue by 9% and adjusted earnings per share by 18% year over year, with strong backlog giving us confidence in the rest of the year. As our growth end markets continue to inflect, we are winning.

Due to our unique competitive advantages and the successful execution of our Ascend strategy, we are well positioned to continue compounding profitable growth. During the third quarter, all three segments again contributed to our organic growth performance, surpassing the high end of our sales and earnings guidance. We achieved record sales of $818 million. This is a 10% increase over the prior year, which is inclusive of 12% overall organic growth.

Order entry momentum continued to accelerate, driving backlog up 35% compared to the prior year. Backlog growth was broad based, with all segments contributing but particular strength coming from our Advanced Technology and Medical segments. Solid execution and volume leverage drove record profit performance for the quarter, delivering EBITDA of $262 million, which was an all-time record and 32% of sales. 25 was also an all-time record for the business.

This was an increase of 19% compared to prior year. I would also like to highlight our free cash flow of $237 million. Our free cash flow conversion of well over 100% of net income continues to be a strength, enabling a healthy mix of shareholder returns and reinvestment in growth. Our balance sheet continues to be in a strong position, giving us plenty of flexibility for fu